Qualigen Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Aixcrypto Holdings

04/11/2022 19:32

* Qualigen Therapeutics Inc  QLGN.OQ   QLGN.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
8 (estimated). 
    * The Los Angeles California-based  company is expected to
report 
a 40.3% increase in revenue to $1.62 million from $1.16 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Qualigen
Therapeutics Inc
is for a loss of 13 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Qualigen
Therapeutics Inc is $4.75​, above​ its last closing price
of $0.22. ​​​

This summary was machine generated November 4 at 19:31 GMT.  All
figures in US dollars  unless otherwise stated